Virtus ETF Advisers’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-936
| Closed | -$100K | – | 492 |
|
|
2023
Q1 | $100K | Sell |
936
-353
| -27% | -$37.9K | 0.06% | 338 |
|
|
2022
Q4 | $142K | Sell |
1,289
-2,895
| -69% | -$318K | 0.07% | 360 |
|
|
2022
Q3 | $247K | Buy |
4,184
+32
| +0.8% | +$1.89K | 0.1% | 292 |
|
|
2022
Q2 | $117K | Sell |
4,152
-737
| -15% | -$20.8K | 0.04% | 393 |
|
|
2022
Q1 | $185K | Sell |
4,889
-282
| -5% | -$10.7K | 0.08% | 203 |
|
|
2021
Q4 | $204K | Sell |
5,171
-3,872
| -43% | -$153K | 0.08% | 201 |
|
|
2021
Q3 | $214K | Sell |
9,043
-476
| -5% | -$11.3K | 0.09% | 254 |
|
|
2021
Q2 | $234K | Buy |
+9,519
| New | +$234K | 0.1% | 233 |
|